Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular heterogeneity and plasticity in liver cancer
Lo‐Kong Chan, Yu‐Man Tsui, Daniel Wai‐Hung Ho, et al.
Seminars in Cancer Biology (2021) Vol. 82, pp. 134-149
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
Zhuo Yu, Yuyao Li, Yue Li, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004297-e004297
Open Access | Times Cited: 77
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 31
Lactate Drives Senescence-Resistant Lineages in Hepatocellular Carcinoma via Histone H2B Lactylation of NDRG1
Lu Li, Jinyun Dong, Chunwei Xu, et al.
Cancer Letters (2025), pp. 217567-217567
Closed Access | Times Cited: 2
Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma
Abdullah Husain, Yung‐Tuen Chiu, Karen Man‐Fong Sze, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 383-396
Closed Access | Times Cited: 59
Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer
Junyu Li, Lin Li, Peimeng You, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 35-49
Closed Access | Times Cited: 30
Immunomodulation of cuproptosis and ferroptosis in liver cancer
Jia-qian Mo, S. Zhang, Qiang Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival
Hao Zhang, Peng Xia, Jie Liu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 15, pp. 4442-4458
Open Access | Times Cited: 49
Network Pharmacology and Bioinformatics Approach Reveals the Multi-Target Pharmacological Mechanism of Fumaria indica in the Treatment of Liver Cancer
Sara Batool, Muhammad Rizwan Javed, Sidra Aslam, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 654-654
Open Access | Times Cited: 35
Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells
Enrico Desideri, Serena Castelli, Coralie Dorard, et al.
Autophagy (2022) Vol. 19, Iss. 1, pp. 152-162
Open Access | Times Cited: 34
Advances in Mass Spectrometry-Based Single Cell Analysis
Siheun Lee, Hung M. Vu, Jung‐Hyun Lee, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 395-395
Open Access | Times Cited: 22
miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2
Mingzhi Xia, Jie Chen, Yingyun Hu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma
Linfu Zhou, Yao Li, Diwei Zheng, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200817-200817
Open Access | Times Cited: 8
A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis
Zijie Wu, Zehua Dong, Jiangti Luo, et al.
Genomics (2024) Vol. 116, Iss. 3, pp. 110831-110831
Open Access | Times Cited: 7
EMT and Inflammation: Crossroads in HCC
Burcu Şengez, Brian I. Carr, Hani Alotaibi
Journal of Gastrointestinal Cancer (2022) Vol. 54, Iss. 1, pp. 204-212
Closed Access | Times Cited: 26
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 5
The Endless Sources of Hepatocellular Carcinoma Heterogeneity
Marina Bárcena‐Varela, Amaia Lujambio
Cancers (2021) Vol. 13, Iss. 11, pp. 2621-2621
Open Access | Times Cited: 29
Design, synthesis and biological evaluation of the positional isomers of the galactose conjugates able to target hepatocellular carcinoma cells via ASGPR-mediated cellular uptake and cytotoxicity
Wenchong Ye, Qun Tang, Tiantian Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115988-115988
Closed Access | Times Cited: 12
PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner
Charles Shing Kam, Daniel Wai‐Hung Ho, Vanessa Sheung‐In Ming, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 6, pp. 1325-1350
Open Access | Times Cited: 11
Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma
Peng Wang, Yanling Li, Bin Cheng, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107975-107975
Open Access | Times Cited: 4
HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity
Rita Andrade, Judith Pérez‐Rojas, Sílvia Silva, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 500-500
Open Access
Construction and application of liver cancer models in vitro
Changmin Shao, Qingfei Zhang, Gaizhen Kuang, et al.
Engineered Regeneration (2022) Vol. 3, Iss. 3, pp. 310-322
Open Access | Times Cited: 18
Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
Sung Hak Lee, Hyun‐Jong Jang
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 754-772
Open Access | Times Cited: 17
Comprehensive analysis on clinical significance and therapeutic targets of LDL receptor related protein 11 (LRP11) in liver hepatocellular carcinoma
Wonbeak Yoo, Ae‐Kyeong Kim, Hae Un Kook, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Association of dietary intake with cancer of the digestive system: a cross-sectional study
Xinxin Qin, Litao Ge, Song Wu, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
SLC7A11, a disulfidptosis-related gene, correlates with multi-omics prognostic analysis in hepatocellular carcinoma
Shizhe Li, Xiaotong Wang, Jie Xiao, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top